Cyprus/Greece/MaltaCyprusGreeceMalta

“On a par with Malaysia”

29.04.2009

Athens –The 5th International Biotechnology Forum (IGBF5), which is to be held May 8-9 in Athens, boasts appearances by three Nobel Prize winners. Andrew Schally, Richard Roberts and Sir Peter Mansfield will speak at the opening ceremony of the two-day-event, which as the website promises “again brings together the crème de la crème of the BioScientific and BioBusiness world.”
Greece might be at the centre of the European biotechnology world for these two days in May, but for the other 363 days of 2009 it will be anything but – at least not yet, according to Nassos Alevizopoulos, a BioBusiness consultant and Senior Vice President of the US biotech company Regulon Inc.
“Despite some recent signs of activity, Greek biotech is embryonic; say at the level of Malaysia,” says Alevizopoulos. Until 2005, he was the CEO of Bionova, the Greek company that hosts IGBF. Today, there are at least 15 R&D-based biotech companies in Greece, he continued, and to increase international outreach in the looming credit crunch, these companies have recently created HellasBio, a non-profit biotech industry association.
As in Italy, the concept of biotech venture capital (BVC) has just begun to emerge in Greece, but “one HellasBio member leads its market in Europe already, while two other innovative Greek biotechs have also attracted professional European BVC for products that were developed locally,“ Alevizopoulos says. If all goes well, he hopes to see “50 companies in 5-10 years.” To reach this ambitious goal, the Greek business leader aims to exploit his country’s large expatriate bioscientific community in the US and EU, and take advantage of repatriated scientists and executives. Meanwhile, Malaysia is not idle. At the BioEurope Spring conference in Milan, the flashiest booth belonged to South-East Asia – not South-East Europe.

Cyprus/Greece/MaltaCyprusGreeceMalta

24.09.2007

Athens – Greek chemical and human and veterinary pharmaceutical company Alapis S.A., which was formed in May by a merger of the Greek firms Veterin, Ebik and Elpharma, is expanding rapidly through acquisitions in south-eastern...

Cyprus/Greece/MaltaCyprusGreeceMalta

11.07.2007

Athens – At the end of May, Greece has launched its official site for the Greek National Contact Point (NCP) for the FP7’s thematic areas “Health“ and “Food, Agriculture and Fisheries, and Biotechnology“ (www.ncp-bionova.gr/)....

Cyprus/Greece/MaltaCyprusGreeceMalta

16.05.2007

Athens – Greek Deputy Agriculture Minister Alexandros Kontos has renewed a decree banning the sale of genetically engineered Mon810 Bt maize varieties for another 18 months after an ultimatum of the European Commission ran out in...

Cyprus/Greece/MaltaCyprusGreeceMalta

16.03.2007

Ioannina – Tumor markers are specific to a certain type of cancer and its developmental stage. They are used to estimate a prognosis for the development and treatment of the cancer. Researchers led by John Ioannidis from the...

Politics / Law, Cyprus/Greece/MaltaCyprusGreeceMalta

21.11.2006

Athens – The Greek government and the European Investment Fund (EIF) signed a Memorandum of Understanding in October, which is to implement ‘Jeremie’. The initiative allows the EU Member States and regions to use part of their...

Cyprus/Greece/MaltaCyprusGreeceMalta

12.05.2006

Athens/Napa - Senetek PLC, a US-biopharmaceutical company focused on developing and co-marketing products in the key categories skincare and dermatological worldwide, announced in March that they have signed a cooperative...

Cyprus/Greece/MaltaCyprusGreeceMalta

17.03.2006

Athens/Paris - US-based drug development company Immuno-Designed Molecules (IDM) Inc. signed in February an exclusive licensing and marketing agreement for its cancer drug Junovan (Muramyl Tripeptide Phosphatidylethanolamine) in...

Cyprus/Greece/MaltaCyprusGreeceMalta

17.03.2006

Athens/Brussels - The European Commission has decided that the Greek national ban of MON810 maize is not properly justified and has therefore ordered to lift the ban. Up to now, Greece had referred to the safeguard clause for...

Cyprus/Greece/MaltaCyprusGreeceMalta

29.01.2006

Athens/Nikosia - Drug developer Samaritan Europe has entered into an exclusive distribution agreement with Three Rivers Pharmaceuticals for the marketing and sales of Amphocil® (amphotericin B cholesteryl sulfate complex for...

Cyprus/Greece/MaltaCyprusGreeceMalta

29.01.2006

Crete - Using an implanted device to make the heart beat faster in pacemaker patients with obstructive sleep apnea-hypopnea syndrome does not help, according to a study of Greek researchers. The physicians around Professor Panos...

Displaying results 11 to 20 out of 47

< Previous 11-20 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-cyprus-greece-malta/browse/1/article/on-a-par-with-malaysia.html

Events

All Events

Partner-Events

Santiago de Compostela (ES)

BioSpain 2014

Stock list

All quotes

TOP

  • WILEX2.35 EUR5.86%
  • FORMYCON8.19 EUR2.37%
  • SARTORIUS96.09 EUR2.22%

FLOP

  • THERAMETRICS0.08 CHF-11.11%
  • MAGFORCE7.05 EUR-3.42%
  • ACTELION109.20 CHF-2.59%

TOP

  • PAION3.26 EUR31.5%
  • EPIGENOMICS3.80 EUR22.6%
  • CO.DON3.04 EUR21.6%

FLOP

  • ADDEX3.19 CHF-20.2%
  • CYTOS0.21 CHF-19.2%
  • MEDIGENE3.85 EUR-17.2%

TOP

  • SANTHERA87.00 CHF2075.0%
  • PAION3.26 EUR246.8%
  • CO.DON3.04 EUR230.4%

FLOP

  • CYTOS0.21 CHF-94.7%
  • THERAMETRICS0.08 CHF-42.9%
  • 4SC1.12 EUR-41.4%

No liability assumed, Date: 23.09.2014


Current issue

All issues

Product of the week

Products